Quick Links

Join AMCP/Renew

AMCP Nexus 2015 Information

Career Center

Update Profile

Mailings Signup (non-member)

Calendar of Events


Student Pharmacists

Residency Information

Corporate Supporters



AMCP Affiliates & Associate Orgs.


AMCP Specialty Pharmacy Central

AMCP Specialty Pharmacy Central
Home to all of AMCP's specialty pharmacy programs, materials and tools.

AMCP Webinar Archives

AMCP Webinar Archives
Listen to AMCP webinars on the issues affecting managed care pharmacy today - at no cost to AMCP members! 

AMCP's Student Pharmacists Center

AMCP's Student Pharmacists Center
Here you'll find tools and resources to help in your transition from pharmacy school to careers in managed care pharmacy.  

Health Care Reform Implementation

Health Care Reform Implementation
'One stop shop' for information on the Affordable Care Act.   

White House Blog Features AMCP Comments
AMCP was included in an Aug. 6 blog entry from The White House’s Office of National AIDS Policy. AMCP was only pharmacy group that commented on newly released “Updated National HIV/AIDS Strategy.”

AMCP Comments on House Passage of 21st Century Cures Act
H.R. 6 would increase funding for FDA and NIH, and includes provision to prevent Rx drug abuse of opioids among at-risk Medicare beneficiaries.

August 2015 Issue of JMCP is Now Available
Current issue includes research on factors associated with failure to achieve SVR in Hepatitis C Genotype 3 patients within an integrated care delivery system.

AMCP Comments on U.S. Supreme Court’s Ruling in King vs. Burwell
AMCP CEO Edith A. Rosato, RPh, IOM, issued a statement on the U.S. Supreme Court’s June 25 ruling in King vs. Burwell and its effect on patients covered under the Affordable Care Act.

AMCP Convenes Experts to Discuss Biosimilars
AMCP convened a group of health care thought leaders from across the country to discuss issues surrounding the marketplace readiness, acceptance and utilization of biosimilars.

New York Times Publishes AMCP Letter
The New York Times published a letter from AMCP CEO Edith A. Rosato, RPh, IOM, objecting to the newspaper’s May 5 editorial supporting government price negotiations of pharmaceuticals.